Author + information
Kiernan MS, Gregory D, Sarnak MJ, Rossignol P, Massaro J, Kociol R, Zannad F, Konstam MA.
Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure
J Am Coll Cardiol HF 2015;3:214–23
The first 2 sentences of the Results section of the Abstract contained some value errors. The corrected sentences are below.
Compared with 50 mg, 150 mg losartan led to a greater reduction in eGFR across time (mean difference: −3.76 ml/min/1.73 m2; p < 0.0001). This difference was driven by early changes, and differences in eGFR after 4 months were not significant (mean difference: 0.42 ml/min/1.73 m2; p = 0.15).
In the Impact of Losartan Dose on Renal Function section in the Results, the first 2 sentences contained value errors. The corrected sentences are below:
eGFR levels were significantly lower at each time point in the 150-mg group compared with the 50-mg group. The mean difference in eGFR between groups across time was −3.76 ml/min/1.73 m2 (95% confidence interval [CI]: −4.07 to -3.46; p < 0.0001) (Figure 1A).
The second to last sentence in the 2nd paragraph of the Discussion contained value errors. The corrected sentence is below:
Interestingly, the treatment effect seen in the Val-HeFT (Valsartan in Heart Failure Trial) analysis between the placebo and valsartan groups was similar to the treatment effect seen between the high-dose and low-dose groups in the present HEAAL analysis (−3.76 ml/min/1.73 m2).
The figure and legend have printed incorrectly. The corrected figure and legend are below.
The online version has been corrected to reflect these changes.
The authors apologize for this error.
- American College of Cardiology Foundation